Cargando…

Can Prescribed Cannabinoids Substitute Cannabis?

Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the fo...

Descripción completa

Detalles Bibliográficos
Autor principal: Batalla, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566991/
http://dx.doi.org/10.1192/j.eurpsy.2022.145
_version_ 1784809289288777728
author Batalla, A.
author_facet Batalla, A.
author_sort Batalla, A.
collection PubMed
description Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the form of barriers and dilemmas, often related to stigma, and deficient information and training. As a result, many people keep on using illicit cannabis for medical problems. In this session we will outline the most common controversies of cannabis prescription, particularly in psychiatry. We will discuss the ethical considerations regarding prescription practices, the benefit-risk assessment, the limitations of the current knowledge, and some potential solutions to respond to the strong demand from patients and families. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9566991
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95669912022-10-17 Can Prescribed Cannabinoids Substitute Cannabis? Batalla, A. Eur Psychiatry Pharmacology Legislative changes in the last years have made possible the prescription of medical cannabis in several countries, often following a growing public demand. However, the medical indications for use and the access to prescribed cannabis are still limited. Prescribers face several challenges in the form of barriers and dilemmas, often related to stigma, and deficient information and training. As a result, many people keep on using illicit cannabis for medical problems. In this session we will outline the most common controversies of cannabis prescription, particularly in psychiatry. We will discuss the ethical considerations regarding prescription practices, the benefit-risk assessment, the limitations of the current knowledge, and some potential solutions to respond to the strong demand from patients and families. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9566991/ http://dx.doi.org/10.1192/j.eurpsy.2022.145 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Pharmacology
Batalla, A.
Can Prescribed Cannabinoids Substitute Cannabis?
title Can Prescribed Cannabinoids Substitute Cannabis?
title_full Can Prescribed Cannabinoids Substitute Cannabis?
title_fullStr Can Prescribed Cannabinoids Substitute Cannabis?
title_full_unstemmed Can Prescribed Cannabinoids Substitute Cannabis?
title_short Can Prescribed Cannabinoids Substitute Cannabis?
title_sort can prescribed cannabinoids substitute cannabis?
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566991/
http://dx.doi.org/10.1192/j.eurpsy.2022.145
work_keys_str_mv AT batallaa canprescribedcannabinoidssubstitutecannabis